本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Corvus Pharmaceuticals, Inc.

3.33
+0.11003.42%
盘后3.330.00000.00%16:32 EDT
成交量:128.69万
成交额:422.32万
市值:2.27亿
市盈率:-3.26
高:3.35
开:3.28
低:3.20
收:3.22
数据加载中...
2023/03/28

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/13

重要事件披露

8-K - Current report
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/13

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/30

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/11/03

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/03

重要事件披露

8-K - Current report
2022/11/03

重要事件披露

8-K/A [Amend] - Current report
2022/10/28

重要事件披露

8-K - Current report
2022/08/08

重要事件披露

8-K - Current report
2022/08/08

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/06/17

重要事件披露

8-K - Current report
2022/05/05

重要事件披露

8-K - Current report
2022/05/05

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/05

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/10

重要事件披露

8-K - Current report
2022/03/10

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals